Cymabay Therapeutics Inc
CBAY·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$4.48
Today
+0.0%
YTD
+0.0%
About
Founded in 1988, CymaBay Therapeutics is a healthcare firm listed on the NASDAQ GS as CBAY. Based in Newark, California, US, the firm creates drugs to combat liver disease and similar diseases, operating nationally. To get more information on CBAY shares, all you need to do is go to this link.
Price chart
Closing price history for CBAY (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-32.75
P/S (TTM)118.45
P/B (TTM)12.65
Market cap$3.73B
Cap tierMid-cap
Industry avg P/E-43.27
Profitability
Gross margin97.81%
EBIT margin-327.23%
Net margin-73512.28%
ROE-64.17%
ROA-36.55%
Earnings & Revenue
Revenue (TTM)$31.07M
Revenue growth (1Y)-100.0%
EPS (TTM)-$0.99
Free cash flow$-72.98M
Total debt$114.49M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.94
Employees101
Next earnings10 May '24
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.